/
Ophthalmology
218Diseases↗
680Pipeline Programs↗
841Active Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
3,691
clinical trials
Completed2,049 · 56%
Unknown status426 · 12%
Recruiting402 · 11%
Terminated238 · 6%
Active, not recruiting207 · 6%
Not yet recruiting201 · 5%
Other168 · 5%
Landscape
Diseases
Age-Related Macular Degeneration
Most programs51
Programs
169
Trials
29
Recruiting
Pre
8
P1
11
P2
11
P3
3
Appr
10
Most programs:
Astellas
AstellasMacular Degeneration
Most trials61
Programs
133
Trials
7
Recruiting
Pre
7
P1
—
P2
—
P3
4
Appr
6
Most programs:
Roche
RocheGlaucoma
Highest activity43
Programs
102
Trials
36
Recruiting
Pre
24
P1
1
P2
3
P3
6
Appr
21
Most programs:
Novartis
NovartisMacular Edema
37 programs73 trialsPhase 2
Dry Eye
328 programs74 trialsApproved
Cataract
734 programs67 trialsApproved
Retinopathy
33 programs67 trialsApproved
Diabetic Macular Edema
231 programs66 trialsApproved
Myopia
214 programs71 trialsApproved
Diabetic Retinopathy
529 programs38 trialsApproved
Retinitis Pigmentosa
28 programs39 trialsApproved
Neovascular Age-Related Macular Degeneration
15 programs61 trialsPhase 3
Thyroid Eye Disease
121 programs39 trialsApproved
Geographic Atrophy
216 programs41 trialsApproved
Uveitis
121 programs28 trialsApproved
Open-Angle Glaucoma
15 programs34 trialsApproved
Dry Eye Disease
11 program38 trialsApproved
Keratitis
18 programs14 trialsApproved
Ptosis
5 programs21 trialsApproved
Strabismus
18 programs6 trialsApproved
Proliferative Diabetic Retinopathy
110 programs11 trialsApproved
Neovascular Age-Related Macular Degeneration (namd)
5 programs16 trialsApproved
Conjunctivitis
6 programs13 trialsApproved
Retinopathy of Prematurity
7 programs11 trialsApproved
Myopia Progression
0 programs17 trials
Geographic Atrophy Secondary to Age-Related Macular Degeneration
21 program15 trialsPhase 2
Leber Congenital Amaurosis
8 programs7 trialsPhase 3
Amblyopia
12 programs13 trialsApproved
Stargardt Disease
25 programs8 trialsPhase 3
Age-Related Macular Degeneration (AMD)
10 programs13 trials
Showing top 30 diseases by activity. 188 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)